First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

This study has been terminated.
Information provided by (Responsible Party):
Baxalta US Inc. Identifier:
First received: August 26, 2010
Last updated: June 26, 2015
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)